Interleukin 2 (IL-2) therapy: potential advantages of locoregional versus systemic administration
- 30 April 1999
- journal article
- research article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 25 (2) , 73-82
- https://doi.org/10.1053/ctrv.1998.0115
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: